Valeo Financial Advisors, LLC Angion Biomedica Corp. Transaction History

Valeo Financial Advisors, LLC

  • $3.49 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$0.8 - $1.0 $21,366 - $26,708
-26,708 Reduced 41.95%
36,951 $29,000
Q1 2022

Apr 28, 2022
BUY
$1.72 - $2.96 $68,813 - $118,423
40,008 Added 169.16%
63,659 $135,000
Q4 2021

Jan 07, 2022
SELL
$2.35 - $9.95 $32,310 - $136,802
-13,749 Reduced 36.76%
23,651 $69,000
Q3 2021

Nov 02, 2021
BUY
$9.31 - $13.25 $348,194 - $495,550
37,400 New
37,400 $365,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email